The company
Candel Therapeutics, Inc.
CADL · Nasdaq
CADL stood above a rising 150-day average in 34 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 4.6% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- Just dropped out
- Weeks in an uptrend
- out for 1
- Industry in uptrend
- 18% -14 in 4 wk
- Insider buys, 12 months
- $6.0M
- Insider sales, 12 months
- $7.1M
- Officials’ trades on record
- 0
- Institutions holding
- 134 (+25)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 34 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Paul Peter TakChief Executive Officer | sold | 59,379at $10.46 | 11 Sep 2026filed 11 Sep 2026 |
| Paul Peter TakChief Executive Officer | sold | 220,866at $11.50 | 10 Sep 2026filed 11 Sep 2026 |
| Seshu TyagarajanChief Technology Officer | sold | 7,000at $12.00 | 17 Aug 2026filed 19 Aug 2026 |
| Francesca BaroneChief Scientific Officer | sold | 23,447at $10.06 | 29 Jun 2026filed 1 Jul 2026 |
| Seshu TyagarajanChief Technology Officer | sold | 7,000at $10.02 | 29 Jun 2026filed 1 Jul 2026 |
| Paul B. ManningDirector | bought | 550,458at $5.45 | 23 Feb 2026filed 26 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| FMR LLCadded · filed 13 Aug 2026 | 10,990,535$113.2M | +3,5180.0% |
| RTW INVESTMENTS, LPunchanged · filed 14 Aug 2026 | 6,422,018$66.1M | 00.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 4,969,040$51.2M | +1,859,998+59.8% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 3,549,823$36.6M | +2,731,265+333.7% |
| ACORN CAPITAL ADVISORS, LLCunchanged · filed 14 Aug 2026 | 3,497,948$36.0M | 00.0% |
| Portolan Capital Management, LLCadded · filed 14 Aug 2026 | 3,490,398$36.0M | +596,073+20.6% |
| Saturn V Capital Management LPadded · filed 14 Aug 2026 | 3,303,686$34.0M | +407,098+14.1% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,694,040$27.7M | +231,283+9.4% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 1,571,021$16.2M | +535,586+51.7% |
| MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026 | 1,093,905$11.3M | +33,819+3.2% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.